Gene Ontology |
GO ID | Evidence Type | GO Description |
GO:0000122 |
IEA |
negative regulation of transcription from RNA polymerase II promoter |
GO:0000978 |
IEA |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
GO:0001046 |
IEA |
core promoter sequence-specific DNA binding |
GO:0001889 |
IEA |
liver development |
GO:0003309 |
ISS |
type B pancreatic cell differentiation |
GO:0003677 |
IEA |
DNA binding |
GO:0003682 |
IEA |
chromatin binding |
GO:0003700 |
TAS |
sequence-specific DNA binding transcription factor activity |
GO:0003705 |
IEA |
RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity |
GO:0005515 |
IEA |
protein binding |
GO:0005622 |
IEA |
intracellular |
GO:0005634 |
IEA |
nucleus |
GO:0005737 |
IEA |
cytoplasm |
GO:0006006 |
IEA |
glucose metabolic process |
GO:0006091 |
TAS |
generation of precursor metabolites and energy |
GO:0006351 |
IEA |
transcription, DNA-templated |
GO:0006357 |
IEA |
regulation of transcription from RNA polymerase II promoter |
GO:0006366 |
IEA |
transcription from RNA polymerase II promoter |
GO:0007224 |
IEA |
smoothened signaling pathway |
GO:0007263 |
IDA |
nitric oxide mediated signal transduction |
GO:0007417 |
IEA |
central nervous system development |
GO:0008134 |
IEA |
transcription factor binding |
GO:0008284 |
IEA |
positive regulation of cell proliferation |
GO:0008285 |
IEA |
negative regulation of cell proliferation |
GO:0009611 |
IEA |
response to wounding |
GO:0009749 |
IEA |
response to glucose |
GO:0009887 |
TAS |
organ morphogenesis |
GO:0010040 |
IEA |
response to iron(II) ion |
GO:0010157 |
IEA |
response to chlorate |
GO:0010260 |
IEA |
organ senescence |
GO:0010942 |
IEA |
positive regulation of cell death |
GO:0014070 |
IEA |
response to organic cyclic compound |
GO:0016331 |
IEA |
morphogenesis of embryonic epithelium |
GO:0030073 |
IDA |
insulin secretion |
GO:0030154 |
IEA |
cell differentiation |
GO:0031016 |
IEA |
pancreas development |
GO:0031017 |
IEA |
exocrine pancreas development |
GO:0031018 |
TAS |
endocrine pancreas development |
GO:0031100 |
IEA |
organ regeneration |
GO:0031667 |
IEA |
response to nutrient levels |
GO:0032024 |
IEA |
positive regulation of insulin secretion |
GO:0032403 |
IEA |
protein complex binding |
GO:0033273 |
IEA |
response to vitamin |
GO:0033993 |
IEA |
response to lipid |
GO:0034097 |
IEA |
response to cytokine |
GO:0035094 |
IEA |
response to nicotine |
GO:0042127 |
IEA |
regulation of cell proliferation |
GO:0042493 |
IEA |
response to drug |
GO:0042593 |
IEA |
glucose homeostasis |
GO:0043201 |
IEA |
response to leucine |
GO:0043279 |
IEA |
response to alkaloid |
GO:0043388 |
IEA |
positive regulation of DNA binding |
GO:0043565 |
IEA |
sequence-specific DNA binding |
GO:0045892 |
IEA |
negative regulation of transcription, DNA-templated |
GO:0045893 |
IEA |
positive regulation of transcription, DNA-templated |
GO:0045944 |
ISS |
positive regulation of transcription from RNA polymerase II promoter |
GO:0046982 |
IEA |
protein heterodimerization activity |
GO:0048565 |
IEA |
digestive tract development |
GO:0048863 |
IEA |
stem cell differentiation |
GO:0051384 |
IEA |
response to glucocorticoid |
GO:0051594 |
ISS |
detection of glucose |
GO:0060290 |
IEA |
transdifferentiation |
GO:0070542 |
IEA |
response to fatty acid |
GO:1902236 |
IEA |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO:2000675 |
IEA |
negative regulation of type B pancreatic cell apoptotic process |